tiprankstipranks
NovoCure Ltd (NVCR)
NASDAQ:NVCR

NovoCure (NVCR) Financial Statements

1,370 Followers

NovoCure Financial Overview

NovoCure's market cap is currently ―. The company's EPS TTM is $-1.805; its P/E ratio is -10.19; NovoCure is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 138.50M$ 133.78M$ 127.32M$ 126.05M$ 122.18M
Gross Profit$ 104.81M$ 101.23M$ 95.23M$ 126.05M$ 92.57M
EBIT$ -41.52M-$ -58.24M$ -62.66M$ -51.08M
EBITDA$ -38.70M-$ -62.13M$ -65.01M$ -52.41M
Net Income Common Stockholders$ -38.76M$ -47.08M$ -49.48M$ -57.42M$ -53.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 870.15M$ 910.62M$ 921.25M$ 941.33M$ 958.71M
Total Assets$ 1.12B$ 1.15B$ 1.15B$ 1.16B$ 1.17B
Total Debt$ 595.26M$ 596.24M$ 590.04M$ 587.48M$ 586.30M
Net Debt$ -274.89M$ -314.37M$ -331.21M$ -353.85M$ -372.41M
Total Liabilities$ 762.07M$ 783.63M$ 752.65M$ 743.33M$ 742.19M
Stockholders Equity$ 359.36M$ 362.50M$ 393.70M$ 415.68M$ 432.15M
Cash Flow-
Free Cash Flow$ -43.36M-$ -26.57M$ -29.67M$ -22.82M
Operating Cash Flow$ -31.57M$ -14.56M$ -19.31M$ -22.74M$ -16.73M
Investing Cash Flow$ 246.22M$ 98.50M$ 17.26M$ -13.90M$ 82.29M
Financing Cash Flow$ 213.00K$ 1.91M$ 1.17M$ 7.50M$ 5.20M
Currency in USD

NovoCure Earnings and Revenue History

NovoCure Debt to Assets

NovoCure Cash Flow

NovoCure Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis